Brief: Ekso Bionics Reports Fourth Quarter And Year End 2022 Results
28/03/2023 23:33
March 28 (Reuters) - Ekso Bionics Holdings Inc EKSO.O :
* EKSO BIONICS REPORTS FOURTH QUARTER AND YEAR END 2022
RESULTS
* EKSO BIONICS HOLDINGS INC- QTRLY LOSS PER SHARE $0.24
Source text for Eikon: ID:nGNXbqtV1v
Further company coverage: EKSO.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Chronoscale
See all newsBrief: Soluna To Form Strategic Partnership With Applied Digital For Wind-Powered AI Data Center In Texas
Brief: Chronoscale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue To $1 Billion And Sale Of Ekso Bionics Business Unit
U.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
U.S. STOCKS ON THE MOVE-Veeva Systems, Dollar General, ChronoScale